Crossref
Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy
Future HIV Therapy · 2007
DOI: 10.2217/17469600.1.1.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future HIV Therapy, 2007. Verfasst von Marc Lallemant und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lallemant, M., & Jourdain, G. (2007). Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy. Future HIV Therapy. https://doi.org/10.2217/17469600.1.1.23
Vancouver
Lallemant M, Jourdain G. Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy. Future HIV Therapy. 2007. doi:10.2217/17469600.1.1.23
BibTeX
@article{Lallemant2007,
author = {Lallemant, Marc and Jourdain, Gonzague},
title = {Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy},
journal = {Future HIV Therapy},
year = {2007},
doi = {10.2217/17469600.1.1.23}
}
EUVIMED